Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
Status:
Completed
Trial end date:
2019-10-28
Target enrollment:
Participant gender:
Summary
Evaluate the effects of L-Threo DOPS on orthostatic hypotension symptoms and other non-motor
symptoms in patients with Multiple System Atrophy (MSA) after 12 weeks following
randomization to continued therapy with droxidopa or placebo.